Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 204

Similar articles for PubMed (Select 18351300)

1.

Most pancreatic cancer resections are R1 resections.

Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, Schirmacher P, Büchler MW.

Ann Surg Oncol. 2008 Jun;15(6):1651-60. doi: 10.1245/s10434-008-9839-8. Epub 2008 Mar 20.

PMID:
18351300
2.

R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.

Rau BM, Moritz K, Schuschan S, Alsfasser G, Prall F, Klar E.

Surgery. 2012 Sep;152(3 Suppl 1):S103-11. doi: 10.1016/j.surg.2012.05.015. Epub 2012 Jul 3.

PMID:
22766366
3.

Different approaches to assessment of lymph nodes and surgical margin status in patients with ductal adenocarcinoma of the pancreas treated with pancreaticoduodenectomy.

Liszka Ł, Pajak J, Zielińska-Pajak E, Gołka D, Mrowiec S, Lampe P.

Pathology. 2010 Feb;42(2):138-46. doi: 10.3109/00313020903494060.

PMID:
20085515
4.

[Ductal adenocarcinoma of the head of the pancreas: a critical study of R1 resection rates].

Delpero JR, Turrini O.

Bull Cancer. 2008 Dec;95(12):1193-8. doi: 10.1684/bdc.2008.0762. Review. French.

PMID:
19091653
5.

Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma.

Jamieson NB, Foulis AK, Oien KA, Going JJ, Glen P, Dickson EJ, Imrie CW, McKay CJ, Carter R.

Ann Surg. 2010 Jun;251(6):1003-10. doi: 10.1097/SLA.0b013e3181d77369.

PMID:
20485150
6.

Pancreatic resection for M1 pancreatic ductal adenocarcinoma.

Shrikhande SV, Kleeff J, Reiser C, Weitz J, Hinz U, Esposito I, Schmidt J, Friess H, Büchler MW.

Ann Surg Oncol. 2007 Jan;14(1):118-27. Epub 2006 Oct 25.

PMID:
17066229
7.

Tumor infiltration in the medial resection margin predicts survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Zhang Y, Frampton AE, Cohen P, Kyriakides C, Bong JJ, Habib NA, Spalding DR, Ahmad R, Jiao LR.

J Gastrointest Surg. 2012 Oct;16(10):1875-82. Epub 2012 Aug 10.

PMID:
22878786
8.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
9.

Peripyloric lymph node metastasis is a rare condition in carcinoma of the pancreatic head.

Gerdes B, Ramaswamy A, Bartsch DK, Rothmund M.

Pancreas. 2005 Jul;31(1):88-92.

PMID:
15968254
10.

[A clinical study about applying different R1 criteria to evaluate pancreatic head ductal adenocarcinoma specimens].

Peng Y, Xiu D, Jiang B, Ma Z, Yuan C, Su J, Shi X, Li L, Tao M.

Zhonghua Wai Ke Za Zhi. 2014 Nov;52(11):834-8. Chinese.

PMID:
25604022
11.

Detrimental effect of postoperative complications on oncologic efficacy of R0 pancreatectomy in ductal adenocarcinoma of the pancreas.

Kang CM, Kim DH, Choi GH, Kim KS, Choi JS, Lee WJ.

J Gastrointest Surg. 2009 May;13(5):907-14. doi: 10.1007/s11605-009-0823-9. Epub 2009 Feb 18.

PMID:
19224295
12.

Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor.

Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, Clausen OP, Gladhaug IP.

BMC Cancer. 2008 Jan 14;8:5. doi: 10.1186/1471-2407-8-5.

13.

Debate: extended resection for pancreatic cancer; the affirmative case.

Nakao A.

J Hepatobiliary Pancreat Surg. 2003;10(1):57-60.

PMID:
12918458
14.

Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens.

Delpero JR, Bachellier P, Regenet N, Le Treut YP, Paye F, Carrere N, Sauvanet A, Autret A, Turrini O, Monges-Ranchin G, Boher JM.

HPB (Oxford). 2014 Jan;16(1):20-33. doi: 10.1111/hpb.12061. Epub 2013 Mar 7.

15.

Redefining the R1 resection in pancreatic cancer.

Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A.

Br J Surg. 2006 Oct;93(10):1232-7.

PMID:
16804874
16.

Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma.

Van den Broeck A, Sergeant G, Ectors N, Van Steenbergen W, Aerts R, Topal B.

Eur J Surg Oncol. 2009 Jun;35(6):600-4. doi: 10.1016/j.ejso.2008.12.006. Epub 2009 Jan 7.

PMID:
19131205
17.

Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.

Adham M, Jaeck D, Le Borgne J, Oussoultzouglou E, Chenard-Neu MP, Mosnier JF, Scoazec JY, Mornex F, Partensky C.

Pancreas. 2008 Nov;37(4):352-7. doi: 10.1097/MPA.0b013e31818166d2.

PMID:
18665012
18.

Second-look operation for unresectable pancreatic ductal adenocarcinoma at a high-volume center.

Michalski CW, Kleeff J, Bachmann J, Alkhatib J, Erkan M, Esposito I, Hinz U, Friess H, Büchler MW.

Ann Surg Oncol. 2008 Jan;15(1):186-92. Epub 2007 Oct 18.

19.

Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?

Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.

Ann Surg. 2013 Apr;257(4):731-6. doi: 10.1097/SLA.0b013e318263da2f.

PMID:
22968073
20.

Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin.

Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, Ghaneh P.

Histopathology. 2009 Sep;55(3):277-83. doi: 10.1111/j.1365-2559.2009.03376.x.

PMID:
19723142
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk